Eighty women attending the Family Planning Clinic showed negative findings when submitted to a special gynaecological and neuro-psychiatric questionnaire, as well as clinical neuro-psychiatric and electroencephalographic examinations, to exclude present or past menstrual troubles, premenstrual tension symptoms and/or neuro-psychiatric illness.
They were divided into eight groups each of ten cases receiving one type of steroid contraceptive throughout the whole period of study.
Repeated submission to the previously used neuro-psychiatric questionnaire as well as clinical neuro-psychiatric examination was carried out every three months. EEG tracings were recorded at the end of the trial.
Neuro-psychiatric side-effects were noted in sixty-one cases (76.2%).
EEG changes were reported in forty-eight cases (60%).
It was concluded that both components of the steroid should be included in the pill preferably in minimum concentration. Selective use or relative increase of either components would be associated with more side-effects.
Get full access to this article
View all access options for this article.
References
1.
Aznar-RamosRGiner-VelazquezJLara-RicaldeRMartinez-ManautouJ (1969) Incidence of side-effects with contraceptive placebo. Amer. J. Obstet. Gynec.105, 7, 1144–1149.
2.
BakerA A (1967) Psychiatric disorders in Obstetrics. Published by Blackwell Scientific Publications, Oxford and Edinburgh.
3.
BakkerC BDightmanC R (1964) Psychological factors in sterility control. Fertility and Sterility15, 559.
4.
BickerstaffE RHolmesJ M (1967) Cerebral arterial insufficiency and oral contraceptives. Brit. Med. J.1, 726–729.
5.
DalyR JKaneF JEwingJ A (1967) Psychosis associated with use of a sequential oral contraceptive. Lancet2, 444–445.
6.
De BarenneD DusserGibbsF A (1942) Variations in the electroencephalogram during the menstrual cycle. Amer. J. Obstet. Gynec.44, 687–690.
7.
Food and Drug Administration report on oral contraceptives (1966) By the advisory committee on obstetrics and gynaecology F D A, August 1, 1966 (available from the US Government Printing Office, Washington, DC).
8.
FrankR T (1931) Hormonal causes of premenstrual tension. Arch. Neurol. and Psychiat.26, 1053.
9.
FreedmanA MKaplanH I (1967) Comprehensive textbook of psychiatry. The Williams & Wilkins Co., Baltimore.
10.
GardnerJ HVan Den NoortSHorensteinS (1967) Cerebrovascular disease in young women taking oral contraceptives. Neurology17, 297.
11.
GlickI D (1967) Mood and behavioural changes associated with the use of oral contraceptive agents. Psychopharmacologia10, 363.
12.
GoldzieherJ WBacerraCGualCLivingstonN BJrMaqueoMMosesL ETietzeC (1964) A new contraceptive. Amer. J. Obstet. Gynec.90, 404.
13.
GrantE C G (1965) Relation of arterioles in the endometrium to headache from oral contraceptives. Lancet1, 1143–1144.
14.
GrantE C GPryse-DaviesJ (1968) Effect of oral contraceptives on depressive mood changes and on endometrial monoamine oxidase and phosphatases. Brit. Med. J.3, 777–780.
15.
GreeneRDaltonK (1953) The premenstrual syndrome. Brit. Med. J.1, 1007–1014.
16.
GroundsA D (1965) Ovarian and synthetic steroids and the control of ovarian function. Ed. ShearmanR P.
17.
HamburgD A (1966) Effects of progesterone on behaviour, published in: Endocrines and the central nervous system. Association for research in nervous and mental disease. Vol. XLIII. The Williams and Wilkins Co., Baltimore, p 251–265.
18.
HeuserGLingG MKluverM (1967) Sleep induction by progesterone in the preoptic area in cats. Electroenceph. Clin. Neurophysiol.22, 122–127.
19.
IdestromC M (1966) Reaction to norethisterone withdrawal. Lancet1, 718.
20.
IsraelS L (1967) Premenstrual tension as an abnormal manifestation of the menstrual cycle. In: ‘Menstrual disorder and sterility‘.Hoeber Medical Division. Harper and Row, Publishers, New York, Evantson, and London.
21.
KaneF JDalyR JEwingJ AKellerM H (1967) Mood and behavioural changes with progestational agents. Brit. J. Psychiat.113, 265–268.
22.
KaneF JTreadwayC REwingJ A (1970) Emotional change associated with oral contraceptives in psychiatric and non-psychiatric patients. (Unpublished data) quoted from Brit. J. Psychiat.116, 165–167.
23.
KawakamiMSawyerC H (1959) Neuroendocrine correlates of changes in brain activity thresholds by sex steroids and pituitary hormones. Endocrinology65, 652–668.
24.
KeelerM HDalyRKaneF J (1964) An acute schizophrenic episode following abrupt withdrawal of Enovid in a patient with previous postpartum psychiatric disorder. Amer. J. Psychiat.120, 11, 1123–1124.
25.
LambW MUlettG AMastersW HRobinsonD W (1953) Premenstrual tension: EEG, hormonal and psychiatric evaluation. Amer. J. Psychiat.109, 11, 840–848.
26.
LindsleyD BRubensteinB B (1937) Relationship between brain potential and some other physiological variables. Proc. Soc. Exp. Biol., N Y, 35, 558.
27.
MarcotteD BKaneF JObristPLiptonM A (1970) Psychophysiologic changes accompanying oral contraceptive use. Brit. J. Psychiat.116, 165–167.
28.
MargerisonJ HAndersonWDawsonJ McCLettichE (1961) The relation of EEG changes to some biochemical and clinical phenomena of normal menstruation and of depression. Excerpta med. (Amst. Int. Congr. Series), 37, 172–173.
29.
MasiA TDugdaleM (1969) Cerebrovascular diseases associated with the use of oral contraceptives: A review of the literature. Second report on the oral contraceptives. Advisory Committee on Obst. and Gynec, Food and Drug Administration, p. 53–61. August 1, 1969.
30.
Mayer-GrossWSlaterERothM (1970) Clinical psychiatry. Published by Bailliere Tindall & Cassell, London.
31.
MearsEGrantE C G (1962) Anovlar as an oral contraceptive. Brit. Med. J.2, 75–79.
32.
MurawskiB JSapirP E (1968) An investigation of mood states in women taking oral contraceptives. Fertility and Sterility19, 50–63.
33.
PhilipsB M (1970) Migraine and the Pills, Background to Migraine, Fourth Migraine Symposium, 11th September 1970, edited by CumingsJ N.
34.
PincusG (1966) Control of conception by hormonal steroidsScience153, 493–500.
35.
ReesL (1953) The premenstrual tension syndrome and its treatment. Brit. Med. J.1, 1014–1016.
36.
RoseD P (1960) Oral contraceptives and depression. Lancet2, 321.
37.
SabourM SFadelH E (1970) The carpal tunnel syndrome, a new complication ascribed to the pill. Amer. J. Obstet. Gynec107, 8, 1265–1267.
38.
SalmonM LWinkelmannJ ZGayA J (1968) Neurophthalmic sequelae in users of oral contraceptives. J.A.M.A.206, 85–91.
39.
SawyerC HKawakamiMKanematsuS (1966) Neuroendocrine aspects of reproduction. Published in: Endocrines and the central nervous system. Association for research in nervous and mental diseases. Vol. XLIII. The Williams & Wilkins Co., Baltimore, p. 59–85.
